Hyaluronic Acid-based Dermal Fillers Global Market Report 2023 – By Product (Single-Phase Product Duplex Product), By Usage (Speciality And Dermatology Clinics Hospitals And Clinics), By Application (Wrinkle Removal Lip Augmentation Rhinoplasty Other Applications) – Market Size, Trends, And Global Forecast 2023-2032

Microbiology Diagnostic Devices And Equipment Market Definition

The microbiology diagnostics devices and equipment market consist of sales of microbiology diagnostics devices and equipment and related services. Microbiology diagnostics devices and equipment are used to diagnose infectious diseases by examining pathogens. Microbiology is the study of the biology of microscopic organisms - viruses, bacteria, algae, fungi, slime molds, and protozoa. Microbiology provides information needed to create vaccines and treatments for diseases. Biologists use microbiology to develop new methods of combating illness. These instruments include incubators, autoclave sterilizers, anaerobic culture systems, blood culture systems, gram strainers, microscopes, mass spectrometers, molecular diagnostic instruments, reagents pathogen-specific kits, and general reagents.

Analgesics are the pain killers that are used to treat mild or severe pain, including musculoskeletal pain, surgical, trauma pain, cancer pain, or another type of pain. Examples of analgesics include codeine, hydrocodone, oxycodone, and methadone. The different types of analgesics are non-opioids and opioids. Non-opioid analgesics are pain relievers available over-the-counter (OTC) and by prescription. They are rapidly being promoted as a desirable, safe, and productive first-line therapeutic alternative to opioid drugs in a range of clinical settings for mild to severe acute and chronic pain. The different types of drugs include prescription analgesics, and OTC analgesics and involve various routes of administration, such as oral, intravenous, rectal, transdermal, and topical. It is used in internal analgesics, and external analgesics and distributed through various channels, such as hospital pharmacies, retail pharmacies, and drug stores. The global analgesics market is segmented – 1) By Type: Non-opioids, Opioids 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores 3) By Route of Administration: Oral, Intravenous, Rectal, Transdermal, Topical 4) By Drug Type: Prescription Analgesics, OTC Analgesics 5) By Application: Internal Analgesics, External Analgesics The global analgesics market size will grow from $111.15 billion in 2022 to $115.13 billion in 2023 at a compound annual growth rate (CAGR) of 3.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size for the global analgesics size is expected to grow to $127.80 billion in 2027 at a CAGR of 2.6%. A significant rise in the prevalence of chronic diseases is driving the analgesics Market. Analgesic drugs, also known as painkillers, are used to treat and reduce chronic or severe pain in the body resulting from various medical conditions. For instance, in September 2022, according to a report shared by WHO, a Switzerland-based health organization, chronic diseases which is sometimes referred to as noncommunicable diseases (NCDs), are conditions that develop over an extended period of time as a result of a combination of genetic, physiological, environmental, and behavioural variables. Noncommunicable diseases (NCDs) account for 41 million annual fatalities, or 74% of all fatalities worldwide. Before the age of 70, 17 million individuals per year pass away from an NCD. These untimely deaths account for 86% of the deaths in low- and middle-income nations. 77% of NCD-related deaths occur in low- and middle-income nations. Therefore, significant rise in the prevalence of chronic disease is driving the growth of the analgesics market. Major players in the analgesics market are Bayer Healthcare, Pfizer, Sanofi, Johnson & Johnson, Novartis AG, GlaxoSmithKline PLC., Reckitt Benckiser (RB), Endo Pharmaceuticals, Bristol-Myers Squibb, and Eli Lilly and Company. The growth of the analgesics market is restricted by the increasing use of biologics for the treatment of inflammatory and neuropathic pain. Biologics are drugs produced from living organisms and include several components derived from humans, animals, or microorganisms. These drugs may contain protein, modified human hormones, or cells that produce substances that suppress or activate parts of the immune system. Biologics can provide greater efficacy compared to analgesics, which provide effective pain relief to only 50% of the patients, and is thus widely used nowadays. Rising demand for biologics can adversely impact the growth of the Analgesics market. For instance, Pfizer and Lilly were granted approval by the FDA for developing Tanezumab, a biologics medicine. Companies in the analgesics market are increasingly focusing on acquisition as a strategy for growth. Leading analgesic drug manufacturers are acquiring smaller companies to gain a competitive advantage and strengthen their market position. These acquisitions are helping companies to expand geographically and gain specialized expertise in the research and development of new products. For instance, Analgesic Solutions, LLC was acquired by WCG. WCG intends to make use of the superior R&D capability of Analgesic Solutions, LLC to grow and position itself as a market leader in the Analgesic Market. The US Food and Drug Administration (FDA) and the UK's Medicines and Healthcare Products Regulatory Agency are some of the regulatory bodies that regulate the Analgesic Market. For instance, the FDA has provided guidelines on the manufacturing process of analgesics, and safety measures regarding the use of both opioid and non-opioid analgesics. FDA also regulates and monitors the misuse and abuse of opioid analgesics. Opioid analgesics are prohibited from being sold without a proper medical prescription. Similarly, the Medicines and Healthcare Products Regulatory Agency in the UK safeguards the public interest through effective regulation of analgesic drugs. WCG, a US-based pharmaceuticals company, acquired Analgesic Solutions, LLC, for an undisclosed amount. WCG's newest acquisition aims to improve test sensitivity in clinical trials, through advising, novel tools, data science, technology, and specialised training. Analgesic Solutions, LLC, is a US-based pharmaceutical company that specialises in the development of new pain medications. North America was the largest region in the analgesics market in 2022. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the global analgesics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the analgesics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The analgesics market consists of sales of codeine, hydrocodone, oxycodone, and methadone. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The analgesics market research report is one of a series of new reports from The Business Research Company that provides analgesics market statistics, including analgesics industry global market size, regional shares, competitors with an analgesics market share, detailed analgesics market segments, market trends, and opportunities, and any further data you may need to thrive in the analgesics industry. This analgesics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Biosimilar therapeutic peptides refer to a peptide drug that is used in place of or in addition to peptide hormones when endogenous levels tend to decline. Therapeutic peptides that are biosimilar have applications in the treatment of cancer, metabolic, pulmonary, cardiovascular, and other illnesses. The two main types of biosimilar therapeutic peptides are innovative and generic. Biosimilar medications are frequently mistaken for generic drugs. Both are marketed as low-cost knockoffs of high-priced name-brand medications. The main distinction is that generics are duplicates of synthetic pharmaceuticals, whereas biosimilars are based on drugs that contain biological organisms as active components. The different routes of administration include the parenteral route, the transdermal route, and others and are used in cancer, cardiovascular disorders, central nervous system, metabolic disorders, infections, haematological disorders, gastrointestinal disorders, dermatology, and respiratory disorders. The global biosimilar therapeutic peptides market is segmented - 1) By Route Of Administration: Parenteral Route, Transdermal Route, Other Route Of Administrations 2) By Application: Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders 3) By Type: Innovative, Generic The biosimilar therapeutic peptides market size grew from $1.21 billion in 2022 to $1.58 billion in 2023 at a compound annual growth rate (CAGR) of 30.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of biosimilar therapeutic peptides is expected to grow from $3.9 billion in 2027 at a CAGR of 25.3%. The increasing ageing population is projected to surge the number of patients with chronic diseases, contributing to the biosimilar therapeutic peptides’ market's growth. Elderly people are more prone to various chronic diseases, which are surging the old age population rapidly across the world and is predicted to continue over the forecast period. According to the World Health Organization (WHO), the world’s population over the age of 60 is expected to reach 2 billion by the end of 2050. Moreover, according to the World Population Prospects, the number of people aged 80 and above is likely to increase from 143 million in 2019 to 426 million in 2050. Biosimilar therapeutic peptides are used for the treatment of various chronic diseases and cancers. The expected increase in the ageing population suffering from various chronic conditions will drive the growth of biosimilar market. Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC., GlaxoSmithKline (GSK), Novartis AG, and Novo Nordisk A/S. The long and costly drug approval process is expected to limit the growth of the biosimilar therapeutic peptide market over the upcoming years. The development, approval, and launch of new drugs is an expensive and prolonged procedure that includes expensive research stages. A new drug has to go through four phases of clinical trials and screening by the regulatory body, including the Food and Drug Administration (FDA) (USA), the Medicines and Healthcare Products Regulatory Agency (MHRA) (UK), and the Medicines and Healthcare Products Regulatory Agency (MHRA) (India). For instance, in September 2020, according to an article shared by Proclinical, a UK-based recruitment agency in the life sciences sector, the average cost to create a new drug is close to $4 billion, however, this cost might occasionally reach $10 billion. No other sector invests more in R&D than the semiconductor industry. According to a recent research, R&D costs are predicted to climb by 3% annually and surpass $203 billion by 2024, therefore, this trend is only projected to continue. Therefore, a long and costly drug approval process is anticipated to hinder the biosimilar therapeutic peptide industry. During the forecast period, the biosimilar therapeutic peptides market is expected to witness growth in research collaborations as well as research funding approvals. Collaborations with other companies and organisations are being prioritised by key companies in order to improve research and development, expand product portfolios, and expand geographical reach.For instance, in January 2020, a UK-based biotechnology company focusing on developing a class of therapeutics based on its proprietary bicyclic peptide technology announced a collaboration with Cancer Research UK to develop BT7401, a new bicyclic immuno-oncology candidate. Cancer Research UK will fund and sponsor the development of a new candidate. In addition to this, Sapience Therapeutics, Inc., a US-based biotechnology company focused on the research & development of peptide therapeutics, announced a research collaboration with the University of Bath (UK) to develop and discover new therapeutic agents for oncology applications. Hence, research collaborations to develop new therapeutic peptides are a major trend in the market. In September 2020, Ligand Pharmaceuticals Incorporated, a US-based biopharmaceutical company, acquired Pfenex Inc. for an undisclosed amount. The acquisition would provide Ligand access to its proprietary protein expression technology. The transaction has the potential to have a materially beneficial scientific and financial impact on our business in the immediate and long terms. Pfenex would provide Ligand with a well-established, tested protein expression platform that would provide a great complement to our vital, exclusive drug discovery and formulation technologies. Pfenex Inc. is a US-based manufacturer of biosimilars, including teriparatide, ranibizumab, and pegfilgrastim. North America was the largest region in the biosimilar therapeutics market in 2022. Middle East is expected to be the fastest growing region in the biosimilar therapeutic peptides market report during the forecast period. The regions covered in the biosimilar therapeutic peptides industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the biosimilar therapeutic peptides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The biosimilar therapeutic peptides market consists of sales of pegfilgrastim, bevacizumab, and adalimumab. Values in this market are "factory gate values," that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The biosimilar therapeutic peptides market research report is one of a series of new reports from The Business Research Company that provides biosimilar therapeutic peptides market statistics, including global market size, regional shares, competitors with a biosimilar therapeutic peptides market share, detailed biosimilar therapeutic peptides market segments, market trends, and opportunities, and any further data you may need to thrive in the biosimilar therapeutic peptides industry. This biosimilar therapeutic peptide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Oral care is crucial for maintaining good oral health, lowering the risk of infection and inflammation in the oral cavity, and preventing systemic infection from the oral cavity. The main product types of oral care are toothpaste, mouth wash and rinse, teeth whitening, dental floss, toothbrush, and orthodontic wax. Toothpaste is used to clean, maintain, and improve the appearance and health of teeth. Toothpaste is a paste or gel dentifrice used to remove food particles and dental plaque from the teeth, control halitosis, and supply active chemicals that fight tooth decay and gum disease. The oral care products are distributed through stores and non-store based. These products are used by hospitals and dental clinics. The global oral care market is segmented - 1) By Product Type: Toothpaste, Mouth Wash and Rinse, Teeth Whitening, Dental Floss, Tooth Brush, Orthodontic Wax 2) By Distribution Channel: Store-based, Non-Store-Based 3) By End User: Hospitals, Dental Clinics The global oral care market size grew from $41.33 billion in 2022 to $44.51 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global oral care market size is expected to grow to $58.56 billion in 2027 at a CAGR of 7.1%. Increased awareness of dental health care is significantly contributing to the growth of the oral care market. Dental or oral health includes the teeth, gums, and mouth and aims to keep the mouth healthy and avoid gum disease and tooth decay. Various factors, including sugar consumption, cigarette use, alcohol use, and poor oral hygiene, are the root causes of oral diseases. Oral care helps to maintain hygiene and keep the mouth disease free. According to the 2022 State of America's Oral Health and Wellness Report, a US-based association that provides crucial education and research and supports key policies to prevent dental disease, 92% of adults and 96% of parents say maintaining good dental health is very important for overall health. One in five (20%) persons think that a problem with their oral health directly impacted their general health. Therefore, awareness of dental health care drives the oral care market growth. Major players in the oral care market are Procter & Gamble Co., Johnson & Johnson Services Inc., GlaxoSmithKline, Church & Dwight Co., Inc., Colgate Palmolive Co., Unilever , Sunstar Suisse, Lion Corporation, Dr Fresh, Dentaid Research Center, Koninklijke Philips NV, Oral-B Laboratories Ltd., Henkel AG & Co., KGaA, Amway, Dabur, and Jordan AS. Technological advancement is a key trend in the oral care market. Major players in the oral care market are adopting CAD/CAM technology for providing oral care services. CAD stands for "computer-assisted design" that uses computer-based software to assist in design processes and producing two-dimensional (2-D) drawings and three-dimensional (3-D) models. Computer-Assisted Manufacture (CAM) helps to automate a production process via software and computer-controlled equipment. In oral care with CAD/CAM technology, the tooth is prepared for the crown by drilling it and then a computer image is taken. The crown is made in-office using a machine that receives this image. For instance, in February 2022, Planmeca, a US-based dental imaging and CAD/CAM equipment manufacturer, introduced the PlanmecaPlanMill 35. The new PlanmecaPlanMill 35 is one of three components of the Planmeca FIT CAD/CAM system. In January 2020, Colgate, a US-based consumer products company specializing in the production, distribution, and provision of household, oral care, health care, personal care, and veterinary products, acquired Hello. Through this acquisition, Colgate will expand its oral care sector and thrive to provide its customers with the best oral care services. Hello is a US-based oral care brand specializing in adult and kid’s toothpaste, mouth rinse, toothbrushes, and floss. Asia-Pacific was the largest region in the oral care market in 2022. The regions covered in the oral care market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the oral care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The oral care market includes revenues earned by entities by tooth-whitening products and denture care materials. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The oral care market research report is one of a series of new reports from The Business Research Company that provides oral care market statistics, including oral care industry global market size, regional shares, competitors with an oral care market share, detailed oral care market segments, market trends and opportunities, and any further data you may need to thrive in the oral care industry. This oral care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pharmaceutical excipients refer to components of a drug delivery system that are not active pharmaceutical ingredients (API) but have undergone acceptable safety evaluation. Excipients, which are not active themselves, allow the drug ingredient to be administered to the patient in the proper form and support the mode and site of action. The main types of products in pharmaceutical excipients are inorganic chemicals and organic chemicals. The pharmaceutical inorganic chemical industry is concerned with the manufacture, physical or chemical characteristics of substances, assay techniques, and applications of inorganic substances used as pharmaceutical aids, treatments, and diagnostics. The different functionalities include fillers and diluents, suspending and viscosity agents, coating agents, bindeflavoringring agents sweetenersners, disintegrants, colorants, lubric, ants, and glidants, and others and involve various formulations such as oral formulation, topical formulation, and parental formulation. The global pharmaceutical excipients market is segmented - 1) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavouring Agents And Sweetners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities 2) By Type Of Formulation: Oral Fromulation, Topical Formulation, Parental Formulation 3) By Product: Inorganic Chemicals, Organic Chemicals The global pharmaceutical excipients market size grew from $8.6 billion in 2022 to $9.11 billion in 2023 at a compound annual growth rate (CAGR) of 5.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global pharmaceutical excipients is expected to grow from $11.55 billion in 2027 at a CAGR of 6.1%. The global surge in the sale of generic drugs contributed to the growth of the pharmaceutical excipients market. Generic drugs are alternatives to the marketed brand-name drug in the same dosage form, safety, strength, route of administration, and quality. According to India Brand Equity Foundation (IBEF), India is the largest provider of generic medicines, the country’s generic drugs account for 20% of the global generic drug exports. Indian pharmaceutical companies received 300 generic drug approvals in the USA. The surge in the demand for generic drugs drives the pharmaceutical excipients market. Major players in the pharmaceutical excipients market report are Archer Daniels Midland Co., Associated British Foods, Dow Chemical Company, Evonik, Croda International PLC., Ashland, BASF SE, The Lubrizol Corporation, and Roquette Frères. Concerns related to safety and quality are expected to limit the growth of the pharmaceutical excipients market. According to the Pharmaceutical Journal, there are certain complications in children with the use of pharmaceutical drugs with excipients. For instance, the colourants used in medicine as colouring agents may lead to sensitivity reactions and hyperactive behaviour in children. Ethanol is another solvent that is widely used in an oral liquid formulation, the use of ethanol mixed medicine for children may have a risk of acute intoxication when overdose, and it may lead to chronic toxicity with long-term use. Concerns related to safety and quality are expected to limit the growth of the pharmaceutical excipients market. The increase in research and development in pharmaceutical formulation to enhance the production process and product quality by using multi-functional excipients is a trend shaping the market. Excipients play a significant role in helping pharmaceutical manufacturers better support patients by increasing compliance and treatment effectiveness. For instance, Evonik’s newly launched EUDRAGIT FS 100 is a solid version of the existing EUDRAGIT FS 30 D. This new multi-functional version allows pharmaceutical companies to use the polymer in many new applications, such as hot-melt extrusion, solvent spray-drying, and solvent coating, which was impossible to achieve in past decades where only the aqueous version was available. In July 2021, Philip Morris International, a US-based cigarette and tobacco manufacturing company acquired Fertin Pharma for $820m. Through this acquisition, PMI will gain significant ability in developing, formulating, and marketing existing as well as new smoke-free platforms. Fertin Pharma is a Denmark-based company that manufactures pharmaceutical excipients. North America is the largest region in the pharmaceutical excipients market in 2022. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pharmaceutical excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pharmaceutical excipients market consists of sales of microcrystalline cellulose, stearic acid, gelatin, and tartaric acid. Values in this market are "factory gate values," that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The pharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical excipients market statistics, including pharmaceutical excipients industry global market size, regional shares, competitors with a pharmaceutical excipients market share, detailed pharmaceutical excipients market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical excipients industry. This pharmaceutical excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

A filling machine refers to a sort of packaging machine that measures a product from bulk as per a predetermined value, such as the level in a container, mass, or volume. The machine then loads the goods into a box, bag, or another packaging container after obtaining the measurement. The main types of filling machines are rotary fillers, volumetric fillers, aseptic fillers, net weight fillers, and others. Rotary filler machines move containers along different circular stations, with each one performing a specific function such as filling, sealing, and capping. The different processes include manual, semi-automatic, and automatic and are used in sectors including the food and beverage industry, pharmaceuticals, cosmetics, and others. The global filling machines market is segmented - 1) By Type: Rotary Fillers, Volumetric Fillers, Aseptic Fillers, Net Weight Fillers, Other Types 2) By Process: Manual, Semi-Automatic, Automatic 3) By Application: Food And Beverage, Pharmaceutical, Cosmetic, Other Applications The global filling machines market size grew from $7.45 billion in 2022 to $7.93 billion in 2023 at a compound annual growth rate (CAGR) of 6.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, causing inflation across goods and services and affecting many markets across the globe. The market size of the filling machines market is expected to grow to $9.66 billion in 2027 at a CAGR of 5.0%. Rising demand for fast food and packaged food is expected to propel the growth of the filling machines market in the coming years. Fast-food and packaged food is a type of food that save time in food acquisition, preparation, and ready-to-eat food from grocery stores. Filling machines are used to fill the product into bags, pouches, or containers such as bin or bottle. For instance, according to Press Information Bureau, a nodal agency of the Government of India, India exported more than $ 2.14 billion worth of final food products in 2020-21. The export of products under ready-to-eat (RTE), ready-to-cook (RTC) and ready-to-serve (RTS) categories rose by more than 23% to $ 1011 million in April to October (2021-22) compared to $ 823 million reported in April to October (2020–21). Therefore, the rise in demand for fast food and packaged food is driving the growth of the hot food processing equipment market. Major players in the filling machines market are Tetra Laval, Krones Group AG, GEA Group AG, Accutek Packaging Equipment, KHS GmbH, Ronchi Mario S.p.A., Coesia Group S.p.A., Scholle IPN Corporation, Uflex Ltd., and Matrix Packaging Machinery. Technological advancement is a key trend gaining popularity in the filling machines market. Many companies operating in the filling machines market are looking for the new products with advanced technologies to strengthen their position in the market. For instance, in November 2021, SIG Group, a Switzerland-based product packaging company launched SIG NEO, a major innovation in filling technology. SIG NEO is the world’s fastest filling machine for family size carton packs with a speed of up to 18,000 packs per hour. It also has a 25% lower carbon footprint per filled pack compared with SIG’s current generation filling machines for family-size packs, due to reduced consumption of water and other utilities and low waste rates. In March 2021, Scholle IPN, a US-based company that manufactures bag-in-box packaging products, completed the acquisition of Bossar Packaging Pvt. Ltd. for an undisclosed amount. This acquisition will leverage the combined capabilities of both businesses to provide one-stop shopping for vertically integrated, sustainable solutions for the global filling machine market. Bossar Packaging Pvt. Ltd. is a US-based company that offers HFFS machines and filling machines for pre-made pouches. Asia-Pacific was the largest region in the filling machines market in 2022. The regions covered in the filling machines market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the filling machines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The filling machine market consists of sales of liquid bottle filling machine, digital liquid filling machine, aseptic liquid filling machine, servo based linear piston filling machine, single head piston filling machine, monoblock bottle filling and capping machine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The filling machines market research report is one of a series of new reports from The Business Research Company that provides filling machines market statistics, including filling machines industry global market size, regional shares, competitors with a filling machines market share, detailed filling machines market segments, market trends and opportunities, and any further data you may need to thrive in the filling machines industry. This filling machines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Fire-resistant building materials are any materials that resist fire and do not melt for a long time, that is, they can withstand heat long enough for the residents of the structure to safely leave the premises. Fire protection materials include concrete, reinforcement steel, gypsum, cast iron, bricks, asbestos cement, timber, stone, glass, and others. They are used to protect construction sites from fire and other safety situations. The main types of fire protection materials for construction are coatings, mortar, sealants and fillers, sheets or boards, spray, preformed devices, putty, cast-in devices, and others. Mortar is a substance used to fill the gaps between bricks and blocks in masonry construction. It's a sand, cement, or lime paste that's applied as a paste and hardens. Clay, cement, lime, and sand are naturally fire and heat-resistant materials. It is used in structural, compartmentation, opening protection, and fire-stopping materials and is implemented in various sectors, such as commercial, industrial, residential, and others. The global fire protection materials for construction market is segmented - 1) By Type: Coatings, Mortar, Sealants And Fillers, Sheets Or Boards, Spray, Preformed Device, Putty, Cast-In Devices, Other Types 2) By Application: Structural, Compartmentation, Opening Protection, Firestopping Materials 3) By End User: Commercial, Industrial, Residential, Other End Users The global fire protection materials for construction market size grew from $4.37 billion in 2022 to $4.88 billion in 2023 at a compound annual growth rate (CAGR) of 11.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the fire protection materials for construction market is expected to grow to $7.05 billion in 2027 at a CAGR of 9.6%. The growing regulations on the mandatory use of fire safety materials are likely to have a positive impact on the growth of fire protection materials for the construction market. Fire safety standards generally aim to reduce the fire-response of products and materials used in various living environments, such as domestic dwellings, household equipment, furnishings and electronics, buildings, and various modes of transportation. Globally, fire safety standards aim to prevent fires from starting by establishing performance-based norms that, if followed, will improve the fire safety of materials and products. For instance, in March 2020, to improve fire safety in buildings in England and Wales, the Home Office introduced the new Fire Safety Bill. The Fire Safety Act 2021 has passed through the parliamentary process and is implemented as a law in the country. Thus, the growing regulation on the use of fire safety materials will support the further growth of the market. Major players in the fire protection materials for construction market are Hilti Corporation, 3M Company, Akzo Nobel N.V., Morgan Advanced Materials, Isolatek International, Sherwin-Williams, Rolf Kuhn GmbH, Specified Technologies Inc., Tremco Incorporated, BASF SE, USG Corporation, Hempel A/S, PPG Industries Inc., Fire Protection Coatings Limited, ETEX SA, and Contego International Inc. Key manufacturers in the fire materials for construction market are constantly focusing on cutting-edge research and technological advancements to create improved fire protection materials that can withstand fire for a longer period and emit less smoke when burned. For instance, in September 2020, CIN, a Portugal-based company developed two new products C-THERM S110 and C-THERM S111 FD, to protect steel structures from fire. C-THERM S110 and C-THERM S111 FD stand out for their long fire resistance times, which protect structures for up to 150 minutes. The technology in the C-THERM range improves structure safety by delaying the time of collapse in the event of a fire and protecting lives and material goods. In October 2020, API Group Inc., a US-based service provider of specialty, safety, and industrial services acquired SK FireSafety Group for $200 million. This acquisition will help API Group Inc.'s safety services and specialty services divisions grow and expand geographically. SK FireSafety Group B.V. is a Netherlands-based company that provides fire protection products for businesses. North America was the largest region in the fire protection materials for construction market in 2022. The regions covered in the fire protection materials for construction market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the fire protection materials for construction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The fire protection materials for the construction market consists of sales of coatings, mortar, sealants & fillers, sheets or boards, spray, preformed devices, putty, cast-in devices, and other fire protection materials for construction. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The fire protection materials for the construction market research report is one of a series of new reports from The Business Research Company that provides fire protection materials for the construction market statistics, including fire protection materials for the construction industry global market size, regional shares, competitors with a fire protection materials for the construction market share, detailed fire protection materials for the construction market segments, market trends and opportunities, and any further data you may need to thrive in the fire protection materials for the construction industry. This fire protection materials for the construction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hyaluronic acid-based dermal fillers refer to a form of dermal filler that is only used for a short period of time. Hyaluronic acid attracts water to the skin, making it more moisturized. It is used to treat shallow and fine wrinkles with Belotero and Restyling Silk, which prevents skin from aging. The main types of hyaluronic acid-based dermal fillers are single-phase products, and duplex products. Single-phase products are widely employed for a variety of skin-related applications to address abnormalities in the soft face tissues since the uncross-linked HA increases elastin and collagen production, making the skin appear more youthful and healthier. They are used in specialty and dermatology clinics, hospitals and clinics for various applications such as wrinkle removal, lip augmentation, rhinoplasty, and other applications. The global hyaluronic acid based dermal fillers market is segmented - 1) By Product: Single-Phase Product, Duplex Product 2) By Usage: Speciality And Dermatology Clinics, Hospitals And Clinics 3) By Application: Wrinkle Removal, Lip Augmentation, Rhinoplasty, Other Applications The global hyaluronic acid-based dermal fillers market size grew from $3.97 billion in 2022 to $4.44 billion in 2023 at a compound annual growth rate (CAGR) of 11.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the hyaluronic acid-based dermal fillers market is expected to grow to $6.65 billion in 2027 at a CAGR of 10.6%. Increasing demand for non-invasive dermatology techniques is driving the growth of hyaluronic acid-based dermal fillers. Deep palpation, x-rays, and blood pressure checks are examples of non-invasive tests that require breaking the skin or entering the body. Most of the treatments are non-invasive and are done by using acid-based dermal fillers as they have minimal risks involved and give long-lasting results. For instance, in February 2022, The American Society of Plastic Surgeons (ASPS), a society for American plastic surgeons, said that every year more than 17 million adults opt for cosmetic surgeries that consist of minimally invasive options such as body contouring, lasers, and injections. This demand is expected to drive the hyaluronic acid-based dermal fillers market. Major players in the hyaluronic acid-based dermal fillers market are Bohus Biotech AB, Allergan, Galderma Laboratories L.P., Merz Pharmaceuticals, Genzyme Corporation, Anika Therapeutics Inc., LG Life Sciences, Bio Plus Co. Ltd., Sculpt Luxury Dermal Fillers Ltd., Bioxis Pharmaceutical, Sinclair Pharma, Laboratories Vivacy, Medicis Aesthetics Holdings, Inc., and Inamed Corp. Technological advancements are shaping the hyaluronic acid-based dermal fillers market. Major companies operating in the hyaluronic acid-based dermal fillers sector are focused on developing new technological solutions to strengthen their position in the hyaluronic acid-based dermal fillers. For instance, in 2021, a new treatment called laser resurfacing treatments was introduced in the market which is more efficient and less invasive, addressing multiple skin concerns. It uses lasers to solve all the skin problems at once making them more appealing. Moreover, the treatment can also be used to cope with the COVID-19 stress. In October 2020 Allergan Aesthetics, an U.S-based manufacturer of drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system acquired Luminera Dermal Filler for an undisclosed amount. Through this acquisition, Allergan Aesthetics will acquire Luminera's entire dermal filler portfolio as well as its RandD pipeline, complementing Allergan Aesthetics' leading dermal filler portfolio with its JUVÉDERM® filler collection. Luminera is a manufacturer and an R and D company for injectable medical devices in the aesthetic medicine field. North America was the largest region in the hyaluronic acid-based dermal fillers market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hyaluronic acid-based dermal fillers market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the hyaluronic acid-based dermal fillers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The hyaluronic acid-based dermal fillers market consists of sales of fat grafting, permanent soft tissue filler, poly-l-lactic acid, calcium hydroxylapatite, and hyaluronic acid. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The hyaluronic acid-based dermal fillers market research report is one of a series of new reports from The Business Research Company that provides hyaluronic acid-based dermal fillers market statistics, including hyaluronic acid-based dermal fillers industry global market size, regional shares, competitors with a hyaluronic acid-based dermal fillers market share, detailed hyaluronic acid-based dermal fillers market segments, market trends and opportunities, and any further data you may need to thrive in the hyaluronic acid-based dermal fillers industry. This hyaluronic acid-based dermal fillers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.